These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 29288626)

  • 1. The P2X7 receptor: A main player in inflammation.
    Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
    Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P2X7 Receptor in Infection and Inflammation.
    Di Virgilio F; Dal Ben D; Sarti AC; Giuliani AL; Falzoni S
    Immunity; 2017 Jul; 47(1):15-31. PubMed ID: 28723547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X7 Receptor as a Therapeutic Target.
    De Marchi E; Orioli E; Dal Ben D; Adinolfi E
    Adv Protein Chem Struct Biol; 2016; 104():39-79. PubMed ID: 27038372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases.
    Mishra A; Behura A; Kumar A; Naik L; Swain A; Das M; Sarangi SS; Dokania P; Dirisala VR; Bhutia SK; Mishra A; Singh R; Dhiman R
    Eur J Pharmacol; 2021 Sep; 906():174235. PubMed ID: 34097884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptor and the NLRP3 inflammasome: Partners in crime.
    Pelegrin P
    Biochem Pharmacol; 2021 May; 187():114385. PubMed ID: 33359010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X7 receptor antagonists: a patent review (2010-2015).
    Park JH; Kim YC
    Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of P2X7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases.
    Morandini AC; Savio LE; Coutinho-Silva R
    Biomed J; 2014; 37(4):169-77. PubMed ID: 25116711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.
    El Idrissi IG; Podlewska S; Abate C; Bojarski AJ; Lacivita E; Leopoldo M
    Curr Med Chem; 2024; 31(11):1361-1403. PubMed ID: 37013427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.
    Baudelet D; Lipka E; Millet R; Ghinet A
    Curr Med Chem; 2015; 22(6):713-29. PubMed ID: 25515510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X7 receptors: channels, pores and more.
    Volonté C; Apolloni S; Skaper SD; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
    Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
    Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
    Scarpellino G; Genova T; Munaron L
    Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of P2X7 antagonists with a focus on CNS indications.
    Rech JC; Bhattacharya A; Letavic MA; Savall BM
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic receptors: new targets for the treatment of gout and fibrosis.
    Gicquel T; Le Daré B; Boichot E; Lagente V
    Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3.
    Zhang Y; Yuan F; Cao X; Zhai Z; GangHuang ; Du X; Wang Y; Zhang J; Huang Y; Zhao J; Hou W
    Toxicol Appl Pharmacol; 2014 Nov; 281(1):1-10. PubMed ID: 25308879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.
    Burnstock G; Knight GE
    Purinergic Signal; 2018 Mar; 14(1):1-18. PubMed ID: 29164451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X7 receptors in the central nervous system.
    Miras-Portugal MT; Ortega F; Gómez-Villafuertes R; Gualix J; Pérez-Sen R; Delicado EG
    Biochem Pharmacol; 2021 May; 187():114472. PubMed ID: 33587917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
    Lee S; Ha H; Jang J; Byun Y
    Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X7 Receptor Orchestrates Multiple Signalling Pathways Triggering Inflammation, Autophagy and Metabolic/Trophic Responses.
    Orioli E; De Marchi E; Giuliani AL; Adinolfi E
    Curr Med Chem; 2017; 24(21):2261-2275. PubMed ID: 28266268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microglia and P2X7 receptors in gliomas.
    Kan LK; Williams D; Drummond K; O'Brien T; Monif M
    J Neuroimmunol; 2019 Jul; 332():138-146. PubMed ID: 31031209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.